Published in J Biol Chem on May 26, 2010
Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat Med (2013) 2.55
Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget (2010) 1.71
Interactions between Hedgehog proteins and their binding partners come into view. Genes Dev (2010) 1.54
Targeting metabolic remodeling in glioblastoma multiforme. Oncotarget (2010) 1.42
Dispatched and scube mediate the efficient secretion of the cholesterol-modified hedgehog ligand. Cell Rep (2012) 1.11
Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis. J Biol Chem (2010) 1.01
Two distinct sites in sonic Hedgehog combine for heparan sulfate interactions and cell signaling functions. J Biol Chem (2011) 0.98
Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells. Clin Cancer Res (2015) 0.96
Lipid modifications of Sonic hedgehog ligand dictate cellular reception and signal response. PLoS One (2011) 0.91
Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases. PLoS One (2012) 0.89
Advanced treatment for basal cell carcinomas. Cold Spring Harb Perspect Med (2014) 0.86
Structural insights into proteoglycan-shaped Hedgehog signaling. Proc Natl Acad Sci U S A (2013) 0.86
AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences. Proteins (2015) 0.86
Hedgehog Signaling in the Maintenance of Cancer Stem Cells. Cancers (Basel) (2015) 0.85
Dual roles of the Cardin-Weintraub motif in multimeric Sonic hedgehog. J Biol Chem (2011) 0.84
An emerging role of Sonic hedgehog shedding as a modulator of heparan sulfate interactions. J Biol Chem (2012) 0.84
Shh signaling guides spatial pathfinding of raphespinal tract axons by multidirectional repulsion. Cell Res (2011) 0.83
Molecular dynamics simulations of sonic hedgehog-receptor and inhibitor complexes and their applications for potential anticancer agent discovery. PLoS One (2013) 0.79
Hedgehog associated to microparticles inhibits adipocyte differentiation via a non-canonical pathway. Sci Rep (2016) 0.79
Differential involvement of Hedgehog signaling in butterfly wing and eyespot development. PLoS One (2012) 0.78
Hedgehog Cholesterolysis: Specialized Gatekeeper to Oncogenic Signaling. Cancers (Basel) (2015) 0.77
Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics. Curr Med Chem (2015) 0.77
Signaling domain of Sonic Hedgehog as cannibalistic calcium-regulated zinc-peptidase. PLoS Comput Biol (2014) 0.76
Dichotomy in Hedgehog signaling between human healthy vessel and atherosclerotic plaques. Mol Med (2012) 0.76
FRET-based system for probing protein-protein interactions between σR and RsrA from Streptomyces coelicolor in response to the redox environment. PLoS One (2014) 0.76
Improving the accuracy of high-throughput protein-protein affinity prediction may require better training data. BMC Bioinformatics (2017) 0.75
The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy. Oncotarget (2017) 0.75
Epithelial heparan sulfate regulates Sonic Hedgehog signaling in lung development. PLoS Genet (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr (2005) 29.38
Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr (2001) 21.01
Hedgehog signaling in animal development: paradigms and principles. Genes Dev (2001) 14.75
A paracrine requirement for hedgehog signalling in cancer. Nature (2008) 8.16
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature (2003) 8.14
Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci U S A (1992) 6.61
Hedgehog signaling in development and cancer. Dev Cell (2008) 6.60
Cholesterol modification of hedgehog signaling proteins in animal development. Science (1996) 5.66
Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature (1999) 3.87
Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. J Biol (2002) 3.85
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci (2009) 3.74
Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell (1996) 3.60
Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr Biol (1999) 3.55
Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates. Development (2006) 3.39
Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol (2003) 3.10
Identification of a palmitic acid-modified form of human Sonic hedgehog. J Biol Chem (1998) 2.95
Autoproteolysis in hedgehog protein biogenesis. Science (1994) 2.87
The cell surface membrane proteins Cdo and Boc are components and targets of the Hedgehog signaling pathway and feedback network in mice. Dev Cell (2006) 2.62
Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell (1994) 2.58
Hedgehog patterning activity: role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain. Cell (1996) 2.39
The product of hedgehog autoproteolytic cleavage active in local and long-range signalling. Nature (1995) 2.24
A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol (2009) 2.21
Cdo functions at multiple points in the Sonic Hedgehog pathway, and Cdo-deficient mice accurately model human holoprosencephaly. Dev Cell (2006) 2.13
A direct requirement for Hedgehog signaling for normal specification of all ventral progenitor domains in the presumptive mammalian spinal cord. Genes Dev (2002) 2.09
Sonic hedgehog protein signals not as a hydrolytic enzyme but as an apparent ligand for patched. Proc Natl Acad Sci U S A (1999) 2.04
Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res (2009) 2.03
Nanoscale organization of hedgehog is essential for long-range signaling. Cell (2008) 2.00
A potential catalytic site revealed by the 1.7-A crystal structure of the amino-terminal signalling domain of Sonic hedgehog. Nature (1995) 1.95
Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev Cell (2008) 1.94
The Hedgehog-binding proteins Gas1 and Cdo cooperate to positively regulate Shh signaling during mouse development. Genes Dev (2007) 1.87
A calcium-dependent antibody for identification and purification of recombinant proteins. Biotechniques (1989) 1.86
Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene (2009) 1.85
A role for Sonic hedgehog in axon-to-astrocyte signalling in the rodent optic nerve. Development (1999) 1.67
Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev Biol (1999) 1.60
BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation. EMBO J (2002) 1.54
Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis (2006) 1.49
Structure of a heparin-dependent complex of Hedgehog and Ihog. Proc Natl Acad Sci U S A (2006) 1.47
The mode of Hedgehog binding to Ihog homologues is not conserved across different phyla. Nature (2008) 1.47
Receptor-mediated endocytosis of soluble and membrane-tethered Sonic hedgehog by Patched-1. Proc Natl Acad Sci U S A (2000) 1.40
Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. Immunity (2000) 1.32
CDO: an oncogene-, serum-, and anchorage-regulated member of the Ig/fibronectin type III repeat family. J Cell Biol (1997) 1.32
Structural insights into hedgehog ligand sequestration by the human hedgehog-interacting protein HHIP. Nat Struct Mol Biol (2009) 1.29
Sonic hedgehog regulates the proliferation, differentiation, and migration of enteric neural crest cells in gut. J Cell Biol (2004) 1.27
Chemoattractive activity of sonic hedgehog in the adult subventricular zone modulates the number of neural precursors reaching the olfactory bulb. Stem Cells (2008) 1.25
The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling. Nat Struct Mol Biol (2009) 1.15
Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition. J Mol Biol (2008) 1.09
Mapping sonic hedgehog-receptor interactions by steric interference. J Biol Chem (2000) 1.09
Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody. J Biol Chem (2004) 1.05
Structural insight into distinct mechanisms of protease inhibition by antibodies. Proc Natl Acad Sci U S A (2007) 1.05
Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog. Bioorg Med Chem Lett (2009) 0.97
Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. Conformation-specific antibodies directed against the phospholipid-binding site on prothrombin. J Biol Chem (1986) 0.96
Unraveling the allosteric mechanism of serine protease inhibition by an antibody. Structure (2009) 0.92
Zinc-dependent structural stability of human Sonic hedgehog. Biochemistry (1999) 0.88
Interfacial metal and antibody recognition. Proc Natl Acad Sci U S A (2005) 0.88
Chick limbs with mouse teeth: an effective in vivo culture system for tooth germ development and analysis. Dev Dyn (2003) 0.80
Pseudo-active sites of protease domains: HGF/Met and Sonic hedgehog signaling in cancer. Biol Chem (2010) 0.79
Quality specifications for the determination of copper, zinc, and selenium in human serum or plasma: evaluation of an approach based on biological and analytical variation. Clin Chem (2008) 0.78
Monoclonal antibodies toward scallop (Patinopecten yessoensis) testis and wheat germ calmodulins. J Biochem (1991) 0.77
A calcium-binding monoclonal antibody that recognizes a non-calcium-binding epitope in the short consensus repeat units (SCRs) of complement C1r. Mol Immunol (1992) 0.76
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem (2002) 14.34
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med (2008) 12.68
Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83
The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature (2010) 10.04
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med (2013) 8.89
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med (2009) 8.55
A paracrine requirement for hedgehog signalling in cancer. Nature (2008) 8.16
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med (2009) 7.23
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol (2006) 6.82
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature (2011) 5.45
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science (2009) 5.40
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell (2008) 5.37
Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov (2006) 5.30
Recurrent R-spondin fusions in colon cancer. Nature (2012) 5.10
Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol (2011) 5.05
Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 4.78
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70
Therapeutic antibody targeting of individual Notch receptors. Nature (2010) 4.56
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell (2009) 4.47
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med (2007) 3.99
Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. Cell (2011) 3.95
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci (2009) 3.74
Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci U S A (2009) 3.13
A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol (2010) 3.09
CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell (2006) 2.89
The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development. Curr Biol (2009) 2.63
K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell (2010) 2.52
Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res (2010) 2.45
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates. Nat Biotechnol (2012) 2.43
The ciliary G-protein-coupled receptor Gpr161 negatively regulates the Sonic hedgehog pathway via cAMP signaling. Cell (2013) 2.42
Paracrine Hedgehog signaling in cancer. Cancer Res (2009) 2.21
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res (2012) 2.19
In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest (2007) 2.18
The hedgehog signaling pathway in cancer. Clin Cancer Res (2006) 2.15
Oncogenic ERBB3 mutations in human cancers. Cancer Cell (2013) 2.06
TULP3 bridges the IFT-A complex and membrane phosphoinositides to promote trafficking of G protein-coupled receptors into primary cilia. Genes Dev (2010) 1.95
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nat Chem Biol (2010) 1.94
Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J (2004) 1.94
Clinical experience with Hedgehog pathway inhibitors. J Clin Oncol (2010) 1.93
Engineering and structural characterization of a linear polyubiquitin-specific antibody. J Mol Biol (2011) 1.93
Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol (2008) 1.92
IL-27 limits IL-2 production during Th1 differentiation. J Immunol (2006) 1.89
Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. J Biol Chem (2004) 1.88
Molecular recognition by a binary code. J Mol Biol (2005) 1.85
Kinetics of hedgehog-dependent full-length Gli3 accumulation in primary cilia and subsequent degradation. Mol Cell Biol (2010) 1.81
TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal (2011) 1.81
A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo. Sci Transl Med (2011) 1.75
Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists. Cancer Res (2011) 1.72
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. Cancer Res (2005) 1.69
Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates. Proc Natl Acad Sci U S A (2005) 1.62
Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell (2009) 1.61
Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists. ACS Chem Biol (2009) 1.60
Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am J Pathol (2006) 1.57
The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site. Structure (2012) 1.57
Hedgehog signaling regulates the generation of ameloblast progenitors in the continuously growing mouse incisor. Development (2010) 1.55
Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol (2005) 1.54
Interactions between Hedgehog proteins and their binding partners come into view. Genes Dev (2010) 1.54
Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol (2005) 1.48
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res (2012) 1.47
The crystal structure of the costimulatory OX40-OX40L complex. Structure (2006) 1.44
Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat Struct Mol Biol (2012) 1.42
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection. Cancer Res (2009) 1.41
IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med (2010) 1.41
Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell (2010) 1.41
Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Blood (2008) 1.39
Loss of the serine/threonine kinase fused results in postnatal growth defects and lethality due to progressive hydrocephalus. Mol Cell Biol (2005) 1.39
Suppressor of fused regulates Gli activity through a dual binding mechanism. Mol Cell Biol (2004) 1.38
Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J Biol Chem (2005) 1.35
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med (2007) 1.34
Human Crossveinless-2 is a novel inhibitor of bone morphogenetic proteins. Biochem Biophys Res Commun (2004) 1.33
Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transduction. Sci Signal (2008) 1.33
Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science (2011) 1.32
Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B. Dev Cell (2011) 1.29
Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem (2003) 1.29
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J Med Chem (2012) 1.27
Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci U S A (2011) 1.23
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. Proc Natl Acad Sci U S A (2013) 1.20
Bi-directional SIFT predicts a subset of activating mutations. PLoS One (2009) 1.19
Structural ties between cholesterol transport and morphogen signaling. Cell (2009) 1.18
Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling. J Biol Chem (2004) 1.18
A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5. J Biol Chem (2002) 1.17
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal (2011) 1.16
The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling. Nat Struct Mol Biol (2009) 1.15